Studies suggested that COVID-19 interaction with ACE2 receptor may cease residual ACE2 activity, elevating angiotensin-2 levels, and several studies stated that binding of ARB to the AT1R may stabilize the AT1R-ACE2 complex and halt SARS-COV-2-ACE2 interface [30]. Here, AGT is linked to COVID-19.